Physician profile
Vivek Y Reddy
NPI 1083672463
$14,901,388.05
in general payments reported to CMS, 2019-2025
32 companies · $1.6M in 2025
The $1.6M reported for 2025 was more than what 99% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119K · 2020: $203K · 2021: $1.3M · 2022: $8.6M · 2023: $1.9M · 2024: $1.2M · 2025: $1.6M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $4.1M · Consulting Fee: $375K · Travel and Lodging: $130K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $12K · Honoraria: $7,500 · Royalty Or License: $2,291 · Grant: $2,000 · Other payment types: $53.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $4,053,895.72 |
| Consulting Fee | $374,989.24 |
| Travel and Lodging | $129,743.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,275.00 |
| Food and Beverage | $12,139.95 |
| Honoraria | $7,500.00 |
| Royalty Or License | $2,291.00 |
| Grant | $2,000.00 |
| Other payment types | $53.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,301,975.44 | 2022-2025 | Micra, Arctic Front Advance, Affera Mapping System |
| Boston Scientific Corporation | $3,643,898.91 | 2019-2025 | General - Therapies, Farapulse, Watchman Access System |
| Ethicon INC. | $276,021.81 | 2020-2023 | |
| Biosense Webster, INC. | $198,453.64 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Abbott Laboratories | $94,346.31 | 2019-2025 | Aveir, Amplatzer Amulet, Mitraclip |
| Circa Scientific, INC. | $87,900.00 | 2023-2025 | |
| Adagio Medical, INC. | $73,616.75 | 2023-2024 | |
| Substrate Hd | $72,157.74 | 2024 | Volta Af-Xplorer |
| Acutus Medical, INC. | $67,462.43 | 2019-2022 | |
| Pulse Biosciences, INC. | $42,000.00 | 2024-2025 | Cellfx, Cellfx |
| Medical Device Business Services, INC. | $9,813.72 | 2019-2025 | Carto 3 |
| Biotronik INC. | $8,540.41 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $8,008.55 | 2022-2025 | Optimizer, Optimizer |
| Medtronic Vascular, INC. | $4,550.00 | 2020 | |
| Novo Nordisk As | $3,750.00 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiofocus, INC. | $2,884.68 | 2019-2025 | Heartlight System |
| Anumana, INC. | $2,291.00 | 2025 | |
| Recor Medical INC | $1,895.15 | 2025 | Paradise Ultrasound Renal Denervation System |
| Ancora Heart, INC. | $893.75 | 2019-2022 | |
| Philips North America LLC | $210.41 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Cardiva Medical, INC. | $188.42 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Ablacon, INC. | $181.39 | 2022-2023 | |
| United Therapeutics Corporation | $104.40 | 2025 | |
| Atricure, INC. | $61.31 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System, Epi-Sense Guided Coagulation System With Visitrax |
| Novartis Pharmaceuticals Corporation | $55.05 | 2021 | |
| Serpex Medical INC | $25.00 | 2024 | |
| Cordis US Corp. | $23.52 | 2024 | Mynx Control |
| Irhythm Technologies, INC. | $23.17 | 2023 | Zio Xt Patch |
| E.R. Squibb & Sons, L.L.C. | $22.71 | 2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $17.11 | 2024 | Xarelto |
| Novo Nordisk INC | $15.27 | 2023 | Wegovy |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,318,626.91 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.